Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Public ClinicalTrials.gov record NCT05327803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung Disease
Study identification
- NCT ID
- NCT05327803
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- AN2 Therapeutics, Inc
- Industry
- Enrollment
- 177 participants
Conditions and interventions
Interventions
- Epetraborole Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2022
- Primary completion
- Dec 17, 2024
- Completion
- Dec 17, 2024
- Last update posted
- Jun 9, 2026
2022 – 2024
United States locations
- U.S. sites
- 49
- U.S. states
- 29
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 423032 | Birmingham | Alabama | 35233 | — |
| 423037 | Tucson | Arizona | 85724 | — |
| 423070 | Sacramento | California | 95817 | — |
| 423069 | San Francisco | California | 94143 | — |
| 423006 | Stanford | California | 94305 | — |
| 423068 | Washington D.C. | District of Columbia | 20037 | — |
| 423075 | Bay Pines | Florida | 33744 | — |
| 423018 | DeLand | Florida | 32720 | — |
| 423034 | Kissimmee | Florida | 34746 | — |
| 423033 | Tampa | Florida | 33606 | — |
| 423054 | Tampa | Florida | 33612 | — |
| 423047 | Tampa | Florida | 33614 | — |
| 423038 | Vero Beach | Florida | 32960 | — |
| 423027 | Atlanta | Georgia | 30342 | — |
| 423076 | Indianapolis | Indiana | 46202 | — |
| 423029 | Iowa City | Iowa | 52242 | — |
| 423015 | Kansas City | Kansas | 66205 | — |
| 423063 | Wichita | Kansas | 67211 | — |
| 423065 | Jefferson | Louisiana | 70121 | — |
| 423042 | New Orleans | Louisiana | 70112 | — |
| 423060 | Baltimore | Maryland | 21201 | — |
| 423003 | Baltimore | Maryland | 21231 | — |
| 423074 | Boston | Massachusetts | 02114-2696 | — |
| 423061 | Boston | Massachusetts | 02115 | — |
| 423078 | Ann Arbor | Michigan | 48109 | — |
| 423031 | Rochester | Minnesota | 55902 | — |
| 423008 | St Louis | Missouri | 63110 | — |
| 423004 | Omaha | Nebraska | 68198 | — |
| 423009 | Lebanon | New Hampshire | 03756 | — |
| 423024 | Manhasset | New York | 11030 | — |
| 423014 | New York | New York | 10017 | — |
| 423013 | New York | New York | 10029 | — |
| 423071 | Chapel Hill | North Carolina | 27599 | — |
| 423072 | Charlotte | North Carolina | 28204 | — |
| 423017 | Durham | North Carolina | 27705 | — |
| 423039 | Winston-Salem | North Carolina | 27103 | — |
| 423079 | Cleveland | Ohio | 44195 | — |
| 423082 | Oklahoma City | Oklahoma | 73104 | — |
| 423007 | Portland | Oregon | 97239 | — |
| 423002 | Philadelphia | Pennsylvania | 19104 | — |
| 423058 | Philadelphia | Pennsylvania | 19107 | — |
| 423045 | Charleston | South Carolina | 29414 | — |
| 423001 | Charleston | South Carolina | 29425 | — |
| 423067 | Nashville | Tennessee | 37232 | — |
| 423081 | Fort Worth | Texas | 76104 | — |
| 423005 | Tyler | Texas | 75708 | — |
| 423012 | Charlottesville | Virginia | 22908 | — |
| 423080 | Edmonds | Washington | 98026 | — |
| 423011 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05327803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05327803 live on ClinicalTrials.gov.